Nordea Investment Management AB Buys 108,849 Shares of HCA Healthcare, Inc. $HCA

Nordea Investment Management AB boosted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 11.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,084,590 shares of the company’s stock after purchasing an additional 108,849 shares during the quarter. Nordea Investment Management AB’s holdings in HCA Healthcare were worth $507,393,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Sovran Advisors LLC boosted its holdings in shares of HCA Healthcare by 1.0% in the third quarter. Sovran Advisors LLC now owns 2,278 shares of the company’s stock valued at $1,063,000 after buying an additional 22 shares during the period. Centerpoint Advisors LLC lifted its position in HCA Healthcare by 11.0% in the 3rd quarter. Centerpoint Advisors LLC now owns 222 shares of the company’s stock valued at $95,000 after acquiring an additional 22 shares in the last quarter. Cary Street Partners Financial LLC increased its holdings in HCA Healthcare by 3.9% during the 3rd quarter. Cary Street Partners Financial LLC now owns 590 shares of the company’s stock worth $251,000 after purchasing an additional 22 shares in the last quarter. Angeles Wealth Management LLC lifted its holdings in shares of HCA Healthcare by 2.4% in the third quarter. Angeles Wealth Management LLC now owns 1,014 shares of the company’s stock valued at $432,000 after purchasing an additional 24 shares in the last quarter. Finally, One Capital Management LLC raised its position in HCA Healthcare by 1.1% in the 3rd quarter. One Capital Management LLC now owns 2,250 shares of the company’s stock valued at $959,000 after buying an additional 24 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total value of $2,020,000.00. Following the transaction, the senior vice president directly owned 44,379 shares in the company, valued at $22,411,395. The trade was a 8.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Michael S. Cuffe sold 1,500 shares of HCA Healthcare stock in a transaction dated Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total transaction of $747,135.00. Following the sale, the executive vice president directly owned 30,003 shares of the company’s stock, valued at $14,944,194.27. The trade was a 4.76% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 15,214 shares of company stock valued at $7,797,595. 1.30% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on HCA. Jefferies Financial Group upped their price target on HCA Healthcare from $535.00 to $590.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. UBS Group increased their target price on shares of HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a report on Monday, February 23rd. Deutsche Bank Aktiengesellschaft boosted their price target on shares of HCA Healthcare from $500.00 to $558.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. JPMorgan Chase & Co. raised their price objective on HCA Healthcare from $420.00 to $535.00 and gave the company a “neutral” rating in a report on Friday, February 20th. Finally, Argus increased their price target on HCA Healthcare from $530.00 to $560.00 and gave the company a “buy” rating in a research report on Friday, February 6th. Sixteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $537.73.

Trending Headlines about HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Jim Cramer publicly recommended buying HCA, calling it a buy in “big clumps,” which can drive retail interest and short‑term inflows. Jim Cramer on HCA Healthcare
• Positive Sentiment: HCA hospitals received regional/national recognition (Ocala hospitals praised for patient safety; HCA Florida North Florida Hospital named to America’s 250 Best Hospitals), which supports brand, referrals and patient volumes. Ocala hospitals honored for excellence in patient safety
• Positive Sentiment: HCA Florida North Florida Hospital included among America’s 250 Best Hospitals, reinforcing quality credentials that can protect pricing and payer relationships. HCA Florida North Florida Hospital among America’s 250 Best Hospitals
• Positive Sentiment: Virginia regulators approved new hospitals/expansions that include HCA projects, supporting medium‑term revenue growth and market share in that region. State approves three Chesterfield hospital projects
• Neutral Sentiment: Human-interest coverage (a North Carolina NICU St. Patrick’s Day feature) highlights community care but is unlikely to move the stock materially. North Carolina NICU Celebrates St. Patrick’s Day
• Negative Sentiment: HCA’s board urged shareholders to reject a proposal for fuller reporting on the aftermath of the 2019 Mission sale — a governance/oversight flashpoint that can raise investor concern and activist interest. HCA board urges shareholders to reject proposal
• Negative Sentiment: An HCA hospital CEO is leaving for Beth Israel Lahey Health — an executive departure that may be seen as local leadership turnover and could modestly concern investors about continuity in affected markets. HCA hospital CEO heads to Beth Israel Lahey Health

HCA Healthcare Price Performance

Shares of HCA opened at $493.61 on Friday. The firm has a 50-day moving average of $510.01 and a 200-day moving average of $473.55. The company has a market cap of $110.36 billion, a PE ratio of 17.39, a price-to-earnings-growth ratio of 1.52 and a beta of 1.34. HCA Healthcare, Inc. has a one year low of $314.43 and a one year high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. The business had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.HCA Healthcare’s quarterly revenue was up 6.7% on a year-over-year basis. During the same quarter last year, the company posted $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be paid a $0.78 dividend. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date is Tuesday, March 17th. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.99%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.